MAGNESIUM Drug Patent Profile
✉ Email this page to a colleague
When do Magnesium patents expire, and when can generic versions of Magnesium launch?
Magnesium is a drug marketed by Santarus, B Braun Medical, Baxter Hlthcare Corp, Aspiro, Exela Pharma, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, Pharmobedient, Amneal, Gland, Milla Pharms, and Mylan Labs Ltd. and is included in twenty-one NDAs.
The generic ingredient in MAGNESIUM is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Magnesium
A generic version of MAGNESIUM was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MAGNESIUM?
- What are the global sales for MAGNESIUM?
- What is Average Wholesale Price for MAGNESIUM?
Summary for MAGNESIUM
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 21 |
| Drug Prices: | Drug price information for MAGNESIUM |
| Drug Sales Revenues: | Drug sales revenues for MAGNESIUM |
| DailyMed Link: | MAGNESIUM at DailyMed |
US Patents and Regulatory Information for MAGNESIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020309-005 | Jan 18, 1995 | AP | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 206485-001 | Mar 15, 2016 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Milla Pharms | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209642-003 | Nov 8, 2021 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hq Spclt Pharma | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207350-004 | Dec 6, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan Labs Ltd | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209911-001 | Sep 14, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
